Cell & Gene Therapy for Cancer
Part of Healthcare - Oncology
 GILD | Gilead Sciences Inc | $156.9b | $134.40 | -1.5% | 5.1M |
 ACLX | Arcellx, Inc. Common Stock | $6.7b | $115.06 | -0.0% | 16.1M |
 NTLA | Intellia Therapeutics, Inc | $2.4b | $11.51 | -4.1% | 3.8M |
 IOVA | Iovance Biotherapeutics, Inc. Common Stock | $1.9b | $5.04 | +7.2% | 22.3M |
 IMTX | Immatics N.V. Ordinary Shares | $1.4b | $9.58 | +2.4% | 366.6K |
 VOR | Vor Biopharma Inc. Common Stock | $1.0b | $18.17 | +4.3% | 868.0K |
 SANA | Sana Biotechnology, Inc. Common Stock | $1.0b | $3.15 | -1.1% | 2.3M |
 IMMX | Immix Biopharma, Inc. Common Stock | $0.7b | $10.25 | +1.9% | 946.3K |
 ALLO | Allogene Therapeutics, Inc. Common Stock | $0.7b | $1.80 | +0.8% | 4.5M |
 ARTV | Artiva Biotherapeutics, Inc. Common Stock | $471.3m | $10.16 | +7.7% | 339.0K |
 IPSC | Century Therapeutics, Inc. Common Stock | $441.9m | $2.26 | -0.2% | 979.4K |
 LYEL | Lyell Immunopharma, Inc. Common Stock | $327.8m | $13.34 | -4.0% | 155.4K |
 FATE | Fate Therapeutics, Inc. | $314.7m | $2.77 | +1.8% | 1.6M |
 TARA | Protara Therapeutics, Inc. Common Stock | $231.6m | $4.11 | +0.6% | 400.0K |
 NKTX | Nkarta, Inc. Common Stock | $202.5m | $2.63 | -0.4% | 291.9K |
 CRBU | Caribou Biosciences, Inc. Common Stock | $174.6m | $1.69 | -0.6% | 1.3M |
 YDES | YD Bio Limited Ordinary Shares | $159.4m | $2.39 | -2.0% | 18.3K |
 ENGN | enGene Therapeutics Inc. Common Stock | $115.9m | $1.82 | -4.7% | 785.8K |
 ATRA | Atara Biotherapeutics, Inc | $103.4m | $8.42 | -2.2% | 79.1K |
 ANIX | Anixa Biosciences, Inc. | $95.3m | $3.46 | +1.2% | 171.6K |
 ACET | Adicet Bio, Inc. Common Stock | $80.8m | $8.13 | -1.5% | 103.7K |
 COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $66.7m | $16.39 | -0.1% | 105.9K |
 TCRX | TScan Therapeutics, Inc. Common Stock | $64.1m | $0.92 | +1.4% | 140.8K |
 INKT | MiNK Therapeutics, Inc. Common Stock | $58.2m | $10.52 | 0.0% | 25.2K |
 ESLA | Estrella Immunopharma, Inc. Common Stock | $44.8m | $0.83 | +12.0% | 251.5K |
 SNTI | Senti Biosciences Holdings, Inc. Common Stock | $34.3m | $0.44 | -5.1% | 402.4K |
 TVGN | Tevogen Bio Holdings Inc. Common Stock | $23.9m | $4.18 | 0.0% | 7.3K |
 CELU | Celularity Inc. Class A Common Stock | $17.3m | $0.80 | 0.0% | 15.5K |
 LNAI | Lunai Bioworks Inc. Common Stock | $14.8m | $2.90 | -2.4% | 15.4K |
 INAB | IN8bio, Inc. Common Stock | $13.5m | $1.33 | 0.0% | 61.7K |
 GDTC | CytoMed Therapeutics Limited Ordinary Shares | $12.2m | $0.99 | 0.0% | 9.1K |
 PMCB | PharmaCyte Biotech, Inc. Common Stock | $8.3m | $0.65 | 0.0% | 107.5K |
 ERNA | Ernexa Therapeutics Inc. Common Stock | $7.8m | $6.50 | 0.0% | 113.9K |
 MBIO | Mustang Bio, Inc. | $5.3m | $0.63 | 0.0% | 24.8K |
 CLDI | Calidi Biotherapeutics, Inc. | $3.3m | $0.12 | +8.7% | 1.5M |